Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Titin Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA568473
Description
Predicted to react with Mouse and Rat samples.
Monoclonal Anti-Titin can be used for study of the elastic filaments within sarcomeric structures. It is also useful as a differentiation marker in the separation of rhabdomyosarcomas from other muscle tumors. By indirect immunofluorescence the antibody displays a typical striated staining pattern on frozen sections of chicken skeletal and cardiac muscle tissues. Stains the region of the A-I junction by indirect immunofluorescence. It shows a decoration line 0.05 mm from the end of the A band in electron micro-graphs. In immunoblotting using total extracts of chicken breast muscle the antibody reacts specifically with both bands of the titin doublet, and showed no reaction with nebulin.
Specifications
| Titin | |
| Polyclonal | |
| Unconjugated | |
| TTN | |
| 1100001C23Rik; 2.7.11.1; 2310036G12Rik; 2310057K23Rik; 2310074I15Rik; AF006999; AV006427; CMD1G; CMH9; CMPD4; Connectin; connectin/titin; D330041I19Rik; D830007G01Rik; DKFZp451N061; EOMFC; FLJ26020; FLJ26409; FLJ32040; FLJ34413; FLJ39564; FLJ43066; HMERF; L56; LGMD2J; mdm; MYLK5; rhabdomyosarcoma antigen MU-RMS-40.14; shru; structural muscle protein titin; titin; titin protein homolog; titin sequence3; TMD; TTN | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 22138, 7273, 84015 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 1 mg/mL | |
| PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| A2ASS6, Q8WZ42 | |
| TTN | |
| Synthesized peptide derived from human Titin [aa 161-210]. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction